AU2001275659A1 - Extracts from sophora species, method for producing the same and their use - Google Patents

Extracts from sophora species, method for producing the same and their use

Info

Publication number
AU2001275659A1
AU2001275659A1 AU2001275659A AU7565901A AU2001275659A1 AU 2001275659 A1 AU2001275659 A1 AU 2001275659A1 AU 2001275659 A AU2001275659 A AU 2001275659A AU 7565901 A AU7565901 A AU 7565901A AU 2001275659 A1 AU2001275659 A1 AU 2001275659A1
Authority
AU
Australia
Prior art keywords
extracts
producing
same
sophora species
sophora
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275659A
Inventor
Clemens Erdelmeier
Hermann Jaggy
Egon Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Publication of AU2001275659A1 publication Critical patent/AU2001275659A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)

Abstract

The invention relates to extracts from Sophora species, to a method for producing the same and to their use in the prophylaxis and therapy of pathological conditions that are caused by estrogen deficiency or by other hormonal dysregulations.
AU2001275659A 2000-06-29 2001-06-29 Extracts from sophora species, method for producing the same and their use Abandoned AU2001275659A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10031651 2000-06-29
DE10031651A DE10031651A1 (en) 2000-06-29 2000-06-29 Extracts from Sophora species, process for their preparation and use
PCT/DE2001/002460 WO2002000236A1 (en) 2000-06-29 2001-06-29 Extracts from sophora species, method for producing the same and their use

Publications (1)

Publication Number Publication Date
AU2001275659A1 true AU2001275659A1 (en) 2002-01-08

Family

ID=7647187

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275659A Abandoned AU2001275659A1 (en) 2000-06-29 2001-06-29 Extracts from sophora species, method for producing the same and their use

Country Status (10)

Country Link
US (1) US7381429B2 (en)
EP (1) EP1294388B1 (en)
JP (1) JP4393062B2 (en)
CN (1) CN1299672C (en)
AT (1) ATE257388T1 (en)
AU (1) AU2001275659A1 (en)
DE (2) DE10031651A1 (en)
ES (1) ES2213705T3 (en)
MX (1) MXPA02012529A (en)
WO (1) WO2002000236A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099725A1 (en) * 2001-02-26 2003-05-29 Global Cancer Strategies Ltd. Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing same
KR100449887B1 (en) * 2003-10-31 2004-09-22 주식회사 렉스진바이오텍 Preparation method of extract of Sophorae Fructus containing isoflavone
KR100509682B1 (en) * 2003-11-26 2005-08-23 주식회사 렉스진바이오텍 Pharmaceutical Composition For Preventing And Treating Of Metabolic Bone Disease Comprising Extract Of Sophorae Fructus
CN100528856C (en) * 2005-12-27 2009-08-19 中国科学院山西煤炭化学研究所 Process for producing kuh-seng total flavone and flavone salt
CN100528855C (en) * 2005-12-27 2009-08-19 中国科学院山西煤炭化学研究所 Process for producing kuh-seng total flavone and flavone salt by kuh-seng
US20090208432A1 (en) * 2006-05-03 2009-08-20 Symrise Gmbh & Co., Kg AH Receptor Antagonists
KR101542703B1 (en) * 2006-10-24 2015-08-06 크렘핀, 로리에 Anti-Resorptive and Bone Building Dietary Supplements and Methods of Use
CN101474239B (en) * 2009-01-21 2013-11-27 沈阳药科大学 Maackia amurensis extract as well as extracting method and use thereof
CN101507750B (en) * 2009-04-01 2012-10-03 大连医科大学 Use of kuhseng total-flavone in preparing medicine
US7897184B1 (en) 2009-08-13 2011-03-01 Access Business Group International Llc Topical composition with skin lightening effect
KR20110097462A (en) * 2010-02-25 2011-08-31 한국 한의학 연구원 Composition for preventing or treating of atopic diseases comprising extract of sophorae tonkinensis radix as active ingredient and method for preparation the same
CN103006761B (en) * 2012-12-06 2015-02-18 江苏大学 Extract of antineoplastic active components in vietnamese sophora root, and preparation method and application thereof
CN103083392B (en) * 2012-12-27 2015-10-07 浙江工业大学 A kind of method at tool isoamylene radical chromocor position in separation and concentration Radix Sophorae Tonkinensis
AU2014269508B2 (en) 2013-05-23 2019-08-01 Fuso Pharmaceutical Industries, Ltd. T-type calcium channel inhibitor
US20190231835A1 (en) * 2016-08-25 2019-08-01 University-Industry Cooperation Group Of Kyung Hee University Pharmaceutical composition containing sophora japonica l. extract as active ingredient for the prevention and treatment of neurodegenerative disorders
CN106749309A (en) * 2016-12-31 2017-05-31 南宁馨艺荣生物科技有限公司 A kind of method of the extraction purification maackiain from subprostrate sophora
US11479537B2 (en) 2017-09-28 2022-10-25 Kinki University T-type calcium channel inhibitor
JP6742537B2 (en) * 2018-04-25 2020-08-19 オリザ油化株式会社 Estrogen activity regulator and agent for improving indefinite complaints using the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1697819A1 (en) 1984-04-26 1991-12-15 В.М.Пойченко и В.А.Борисенко Method of chronic prostatitis treatment
JPH0273079A (en) * 1988-09-09 1990-03-13 Daicel Chem Ind Ltd Production of flavonoid
CN1099259A (en) * 1993-08-27 1995-03-01 阿坝藏族羌族自治州医药公司 Health and skin-caring additive of cosmetics and toilet articles
JP3327699B2 (en) * 1994-08-31 2002-09-24 一丸ファルコス株式会社 Antibacterial / preservative and cosmetics containing kujin extract
CN1053829C (en) 1995-12-13 2000-06-28 韩贵民 Prepn of Chinese medicine for gynopathy
CN1060665C (en) 1996-05-10 2001-01-17 潘兴光 Medicine for heart disease
JPH1017461A (en) * 1996-06-28 1998-01-20 Shiseido Co Ltd Preparation for external use for improving skin roughness
JPH1017460A (en) * 1996-06-28 1998-01-20 Shiseido Co Ltd Antiageing agent
CN1095362C (en) * 1996-09-26 2002-12-04 内蒙古苦参生化集团有限责任公司 Bath lotion containing total alkaloid of sophora alopecuroide
JPH1135454A (en) * 1997-07-22 1999-02-09 Meiji Milk Prod Co Ltd Antitumor agent
EP0998824A1 (en) * 1997-07-28 2000-05-10 IDT INTERNATIONAL DIGITAL TECHNOLOGIES DEUTSCHLAND GmbH Method and apparatus for compression of video images and image residuals
CN1175458A (en) 1997-09-05 1998-03-11 张玉杰 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases

Also Published As

Publication number Publication date
DE10031651A1 (en) 2002-01-17
US7381429B2 (en) 2008-06-03
CN1633301A (en) 2005-06-29
CN1299672C (en) 2007-02-14
ATE257388T1 (en) 2004-01-15
EP1294388B1 (en) 2004-01-07
JP2004501201A (en) 2004-01-15
JP4393062B2 (en) 2010-01-06
EP1294388A1 (en) 2003-03-26
MXPA02012529A (en) 2004-05-05
ES2213705T3 (en) 2004-09-01
US20030180394A1 (en) 2003-09-25
DE50101304D1 (en) 2004-02-12
WO2002000236A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2001275659A1 (en) Extracts from sophora species, method for producing the same and their use
AU2001276299A1 (en) Therapeutical use of sophora flavescens or sophora subprostrata extracts
AU2003299585A8 (en) Water-soluble products and methods of making and using the same
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
GB2380775A (en) Gearbox
MXPA02004666A (en) Recombinant gelatins.
WO2002051449A3 (en) Composition and process for bone growth and repair
AU2002358667A1 (en) Scented polymer capsules and the production thereof
AU2001293202A1 (en) Process for extracting compounds from plants
MXPA03010322A (en) Method for producing polyisocyanates.
WO2004031402A3 (en) Methylation profile of cancer
WO2003050137A3 (en) Toll-like receptor 4 mutations
AU2003236817A1 (en) Plant extracts
WO2000022019A3 (en) Coupled block copolymers and process for producing the block copolymers
AU2001281931A1 (en) Improved microgels and films
AU4288300A (en) Unsupported flat linoleum structure and method of producing same
WO2002028432A3 (en) Stem cell-based methods for preventing and treating tumor
CA97011S (en) Control lever for earth moving machines
AU2002226308A1 (en) Method for producing dnda
AU2001250429A1 (en) Method for producing 2-alkyl-3-chlorophenols
AU2002358064A1 (en) Bipolar plate and method for the production thereof
AU2003222462A1 (en) Method of performing soojichim acupuncture using bodycopy
AU2003264707A1 (en) Use of a chrysanthellum extract
AU6584601A (en) Method for producing indols
MXPA03005400A (en) Method for the preparation of 11(12)-pentadecen-15-olides.